Konstantinides SV; Meyer G; Lang I; Verschuren F; Meyer G; Meneveau N; Charbonnier B; Bouvaist H; Geibel A; Beyer-Westendorf J; Dellas C; Empen K; Kupatt C; Galiè N; Giancarlo; Becattini C; Salvi A; Pruszczyk P; Torbicki A; Franca A; Lohmann C; Kozak M; Jiménez D; Kucher N; Goldhaber SZ; Danays T; Bluhmki E; Gallula P., Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial, «AMERICAN HEART JOURNAL», 2012, 163, pp. 33 - 38 [articolo]
Attinà D; Valentino M; Galiè N; Modolon C; Buia F; de Luca F; Bacchi-Reggiani ML; Zompatori M., Application of a new pulmonary artery obstruction score in the prognostic evaluation of acute pulmonary embolism: comparison with clinical and haemodynamic parameters [Applicazione di un nuovo score di ostruzione vascolare nella valutazione prognostica dell'embolia polmonare acuta. Confronto con i parametri clinico-emodinamici], «LA RADIOLOGIA MEDICA», 2011, 116, pp. 230 - 245 [articolo]
Galie' N; Manes A; Palazzini M; Leci E, Conventional Medical Therapies in the treatment of pulmonary hypertension, in: PEACOCK A NAEIJE R RUBIN L, Pulmonary Hypertension, LONDON, Hadder Arnold, 2011, pp. 303 - 313 [capitolo di libro]
Lau EM; Manes A; Celermajer DS; Galiè N., Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward., «EUROPEAN HEART JOURNAL», 2011, 32, pp. 2489 - 2498 [articolo]
Jing ZC; Yu ZX; Shen JY; Wu BX; Xu KF; Zhu XY; Pan L; Zhang ZL; Liu XQ; Zhang YS; Jiang X; Galiè N, Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION) Study Group. Vardenafil in pulmonary
arterial hypertension: a randomized, double-blind, placebo-controlled study, «AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE», 2011, 183, pp. 1723 - 1729 [articolo]
Renzulli M, Lucidi V, Gotti E, Mosconi C, Galiè N, Golfieri R, Gd-EOB-DTPA-enhanced MRI of the liver in pre-capillary pulmonary hypertension: incidence of Large regenerative Nodules (LRN). Preliminary data, «HEPATOLOGY INTERNATIONAL», 2011, 5, pp. 480 - 480 [abstract]
Galiè N; Hoeper MM; Gibbs JS; Simonneau G, Liver toxicity of sitaxentan in pulmonary arterial hypertension., «EUROPEAN RESPIRATORY JOURNAL», 2011, 37, pp. 475 - 476 [replica/breve intervento]
Galiè N; Hoeper MM; Simon J; Gibbs R; Simonneau G; Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)., Liver toxicity of sitaxentan in pulmonary arterial hypertension., «EUROPEAN HEART JOURNAL», 2011, 32, pp. 386 - 387 [articolo]
Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ; behalf of the SUPER-2 Study Group., Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension: The SUPER-2 Study., «CHEST», 2011, 140, pp. 1274 - 1283 [articolo]
Galie' N; Manes A; Palazzini M.; Leci E, Pulmonary hypertension, in: TUBARO M, The ESC Textbook of Acute and Intensive cardiac care, OXFORD, Oxford University Press, 2011, pp. 650 - 659 [capitolo di libro]
Galie' N; Manes A; Palazzini M, Pulmonary Hypertension: Lessons from Adults, in: BEGHETTI M, Pediatric Pulmonary Hypertension, MUNICH, Elsevier, 2011, pp. 1 - 5 [capitolo di libro]
Barst RJ; Oudiz RJ; Beardsworth A; Brundage BH; Simonneau G; Ghofrani HA; Sundin DP; Galiè N; Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group., Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension., «THE JOURNAL OF HEART AND LUNG TRANSPLANTATION», 2011, 30, pp. 632 - 643 [articolo]
Vonk Noordegraaf A; Galiè N, The role of the right ventricle in pulmonary arterial hypertension, «EUROPEAN RESPIRATORY REVIEW», 2011, 20, pp. 243 - 253 [articolo]
Berger RM; Beghetti M; Galiè N; Gatzoulis MA; Granton J; Lauer A; Chiossi E; Landzberg M., Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis., «INTERNATIONAL JOURNAL OF CARDIOLOGY», 2010, 144, pp. 373 - 378 [articolo]
Galiè N; Simonneau G; Barst RJ; Badesch D; Rubin L., Clinical worsening in trials of pulmonary arterial hypertension: results and implications., «CURRENT OPINION IN PULMONARY MEDICINE», 2010, 16, pp. s16 - s19 [articolo]
